Leading global drug development consultancy Boyds has strengthened its team with the appointment of senior regulatory affairs professional Kelsey Lenoch.

Kelsey joins Boyds as Associate Director, Regulatory Affairs in the US, bringing with her 15 years of experience in clinical research and drug development.

• Membrane proteins synthesized and purified within 48 hours.
• Active membrane transporter, MsbA and integral membrane protein, ZMPSTE24 synthesized

Creative Biolabs stands out in the race as brain diseases fuel a surge in demand for NHP biospecimens—cerebrospinal fluid (CSF)—functioning as the gold standard for validating next-gen brain therapies.

A landmark study about gene therapy recently reported in Nature Biotechnology indicating 27% cognitive improvement in Alzheimer's mice using circular RNA has set labs scrambling for high-quality NHP samples that are firmly determined as the gold standard for bridging preclinical breakthroughs to human trials.

Working with leading research institutions, Amsbio has established itself as a premier supplier of high quality Heparan Sulfate (HS) monoclonal antibodies driving breakthroughs in Glycobiology research.

Cambridge, UK, 10 April 2025: Source BioScience UK Ltd, an industry-leading provider of genomic services and histopathology diagnostics, today announced it had completed the acquisition of Cambridge Clinical Laboratories (CCL), a leading Cambridge-based provider of clinical, personalised healthcare testing services. The acquisition bolsters the Company’s clinical diagnostics portfolio by leveraging the expertise of the CCL team and new state-of-the-art clinical lab facilities at Vision Park in Cambridge, providing streamlined testing services for both preclinical and clinical research.